Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply
August 27, 2021 07:15 ET | BioNTech SE
BERLIN, GERMANY, August 27, 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) agreed today to evaluate the establishment of sustainable vaccine manufacturing capabilities...
Gemeinsames Kommuniqué: BioNTech evaluiert Optionen zur Herstellung von mRNA-Impfstoffen in Ruanda und Senegal zur Unterstützung einer langfristigen Impfstoffversorgung in Afrika
August 27, 2021 07:15 ET | BioNTech SE
BERLIN, DEUTSCHLAND, 27. August, 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen”) gab heute bekannt, den Aufbau nachhaltiger Produktionsmöglichkeiten für...
BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on the African Continent
July 26, 2021 10:00 ET | BioNTech SE
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022BioNTech is evaluating sustainable mRNA vaccine production capacities...
BioNTech gibt Update zu Entwicklungsplänen für nachhaltige Lösungen gegen Infektionskrankheiten auf dem afrikanischen Kontinent
July 26, 2021 10:00 ET | BioNTech SE
BioNTech will den ersten mRNA-basierten Impfstoff zur Malaria-Prävention entwickeln und plant den Start einer klinischen Studie bis Ende 2022 BioNTech prüft nachhaltige Lösungen für...
22157.jpg
Insights on the Hepatitis Diagnostic Tests Global Market to 2026 - by Test Type and Region
May 27, 2021 06:53 ET | Research and Markets
Dublin, May 27, 2021 (GLOBE NEWSWIRE) -- The "Hepatitis Diagnostic Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
TIP_link_300x300.jpg
Malaria Treatment Market to Outstrip $2,126.42 Million by 2027 Growing Sturdy at 4.4% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
April 21, 2021 08:00 ET | The Insight Partners
Pune, India., April 21, 2021 (GLOBE NEWSWIRE) -- Malaria Treatment Market: Key InsightsAccording to our new research study on “Malaria Treatment Market to 2027 – Global Analysis and Forecast – by...
Manus_Bio_logo_1112018_gc.jpg
Manus Bio Awarded Additional Funding to Support its Artemisinin Development Program
April 01, 2021 10:38 ET | Manus Bio
CAMBRIDGE, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...
OPEN SANS HH STACKED_2.jpg
New Research Reveals Gazelle Diagnostic Device Outperformed Rapid Diagnostic Test for P. Vivax Malaria, Detected Challenging Types of Malaria, and Provided Affordable Sickle Cell Disease Detection
November 16, 2020 16:10 ET | Hemex Health
PORTLAND, Ore., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Hemex Health, an innovator in point-of-care diagnostic technologies, announced today that researchers will present five scientific posters at the...
OPEN SANS HH STACKED_2.jpg
New Research Shows Gazelle Diagnostic Device Outperformed Rapid Diagnostic Test for P. Vivax Malaria, Detected Challenging Types of Malaria, and Provided Accurate Sickle Cell Disease Detection
November 15, 2020 14:00 ET | Hemex Health
PORTLAND, Ore., Nov. 15, 2020 (GLOBE NEWSWIRE) -- Hemex Health, an innovator in point-of-care diagnostic technologies, announced today that researchers will present five scientific posters at the...
OPEN SANS HH STACKED_2.jpg
NIH Awards Prize to Hemex Health’s Non-Invasive Sickle Cell, Malaria, Anemia Rapid Test (“SMART”) Diagnostic Technology
October 26, 2020 08:00 ET | Hemex Health
PORTLAND, Ore., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Researchers from Hemex Health, Medtronic plc, Case Western Reserve University, and the University of Nebraska Medical Center’s International...